Genetic diversity of hepatitis C virus and resistance associated substitutions to direct-acting antiviral treatment in Colombia
Hepatitis C virus (HCV) infection is one of the leading risk factors for end-stage liver disease development worldwide. This RNA virus displays high genetic diversity with 8 genotypes and 96 subgenotypes with heterogeneous geographical distribution around the world. In this study, we carried out an...
Main Authors: | Maria C. Lopez-Osorio, José Aldemar Usme-Ciro, José William Martínez, Dioselina Peláez-Carvajal, Javier Hernández, Sergio Hoyos, Juan Carlos Restrepo, Maria-Cristina Navas |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-09-01
|
Series: | Virus Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0168170222001757 |
Similar Items
-
Molecular Epidemiology and Baseline Resistance of Hepatitis C Virus to Direct Acting Antivirals in Croatia
by: Petra Simicic, et al.
Published: (2022-07-01) -
Outcomes and Follow-Up after Hepatitis C Eradication with Direct-Acting Antivirals
by: Erica Nicola Lynch, et al.
Published: (2023-03-01) -
Hepatitis C Clearance by Direct-Acting Antivirals Impacts Glucose and Lipid Homeostasis
by: Christiana Graf, et al.
Published: (2020-08-01) -
Prevalence of hepatitis B and C virus infection among leprosy patients in a leprosy-endemic region of central Brazil
by: José María Hernández Ramos, et al.
Published: (2011-08-01) -
HEPATITIS D: A REVIEW
by: Bader Faiyaz Zuberi
Published: (2007-04-01)